- Drug Pipelines
- August 2024
- 150 Pages
Global
From €3397EUR$3,750USD£2,928GBP
- Report
- March 2025
- 226 Pages
Global
From €2265EUR$2,500USD£1,952GBP
- Report
- April 2025
- 250 Pages
Global
From €3619EUR$3,995USD£3,119GBP
- Report
- January 2025
- 343 Pages
Global
From €4347EUR$4,799USD£3,747GBP
- Report
- October 2024
- 193 Pages
From €3211EUR$3,545USD£2,768GBP
€3568EUR$3,939USD£3,076GBP
From €4439EUR$4,900USD£3,826GBP
- Report
- August 2024
- 132 Pages
Global
From €2709EUR$2,990USD£2,335GBP
- Report
- May 2025
- 189 Pages
Global
From €3211EUR$3,545USD£2,768GBP
€3568EUR$3,939USD£3,076GBP
- Report
- May 2025
- 182 Pages
Global
From €3211EUR$3,545USD£2,768GBP
€3568EUR$3,939USD£3,076GBP
- Report
- May 2025
- 192 Pages
Global
From €3211EUR$3,545USD£2,768GBP
€3568EUR$3,939USD£3,076GBP
- Report
- May 2025
- 186 Pages
Global
From €3211EUR$3,545USD£2,768GBP
€3568EUR$3,939USD£3,076GBP
- Report
- May 2025
- 180 Pages
Global
From €3211EUR$3,545USD£2,768GBP
€3568EUR$3,939USD£3,076GBP
- Report
- May 2025
- 191 Pages
Global
From €3211EUR$3,545USD£2,768GBP
€3568EUR$3,939USD£3,076GBP
- Report
- May 2025
- 181 Pages
Global
From €3211EUR$3,545USD£2,768GBP
€3568EUR$3,939USD£3,076GBP
- Report
- May 2025
- 199 Pages
Global
From €3211EUR$3,545USD£2,768GBP
€3568EUR$3,939USD£3,076GBP
- Report
- May 2025
- 185 Pages
Global
From €3211EUR$3,545USD£2,768GBP
€3568EUR$3,939USD£3,076GBP
- Report
- May 2025
- 187 Pages
Global
From €3211EUR$3,545USD£2,768GBP
€3568EUR$3,939USD£3,076GBP
- Report
- May 2025
- 182 Pages
Global
From €3211EUR$3,545USD£2,768GBP
€3568EUR$3,939USD£3,076GBP
- Report
- May 2025
- 196 Pages
Global
From €3211EUR$3,545USD£2,768GBP
€3568EUR$3,939USD£3,076GBP
- Report
- May 2025
- 196 Pages
Global
From €3211EUR$3,545USD£2,768GBP
€3568EUR$3,939USD£3,076GBP

The Respiratory Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat respiratory diseases. These drugs are used to treat a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Commonly prescribed respiratory drugs include bronchodilators, corticosteroids, and antibiotics.
The Respiratory Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Companies in the market include GlaxoSmithKline, AstraZeneca, Merck & Co., Novartis, and Boehringer Ingelheim. These companies are constantly researching and developing new drugs to treat respiratory diseases, as well as improving existing treatments. Show Less Read more